Page last updated: 2024-10-21

huperzine a and Idiopathic Parkinson Disease

huperzine a has been researched along with Idiopathic Parkinson Disease in 1 studies

huperzine A: RN given refers to 5R-(5alpha,9beta,11E)-isomer; structure given in first source
huperzine A : A sesquiterpene alkaloid isolated from a club moss Huperzia serrata that has been shown to exhibit neuroprotective activity. It is also an effective inhibitor of acetylcholinesterase and has attracted interest as a therapeutic candidate for Alzheimer's disease.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Guo, X1
Wu, Y1
Wang, Q1
Zhang, J1
Sheng, X1
Zheng, L1
Wang, Y1

Other Studies

1 other study available for huperzine a and Idiopathic Parkinson Disease

ArticleYear
Huperzine A injection ameliorates motor and cognitive abnormalities via regulating multiple pathways in a murine model of Parkinson's disease.
    European journal of pharmacology, 2023, Oct-05, Volume: 956

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Acetylcholinesterase; Animals; Cognition; Disease Mode

2023